Molecular aspects of drug recognition by specific T cells

Current Drug Targets

Volumn 4, Issue 1, 2003, Pages 1-11

  Britschgi, Markus ^a   von Greyerz, Salome ^a   Burkhart, Christoph ^a   Pichler, Werner J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BETA LACTAM ANTIBIOTIC; CARRIER PROTEIN; CELECOXIB; CEPHALOSPORIN; DRUG METABOLITE; FREUND ADJUVANT; HAPTEN; HLA ANTIGEN CLASS 2; LIDOCAINE; MEPIVACAINE; PENICILLIN G; PEPTIDE; SULFADIAZINE; SULFADIMIDINE; SULFADOXINE; SULFAMERAZINE; SULFAMETHIZOLE; SULFAMETHOXAZOLE; SULFAMETHOXIDIAZINE; SULFAMETHOXIPYRIDAZINE; SULFAMETOXYDIAZINE; SULFAMOXOLE; SULFAPYRIDINE; SULFISOMIDE; SULFONAMIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGENICITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELLULAR IMMUNITY; CYTOLOGY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG UPTAKE; HAPTEN CARRIER COMPLEX; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NONHUMAN; PUSTULE; RASH; RETROSPECTIVE STUDY; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CARRIER PROTEINS; DRUG HYPERSENSITIVITY; HAPTENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LIGANDS; MAJOR HISTOCOMPATIBILITY COMPLEX; PHARMACEUTICAL PREPARATIONS; RECEPTORS, IMMUNOLOGIC; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES;

EID: 0037244940     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450033347082     Document Type: Review

References (72)

1. Hoigne, R.; Schlumberger, H. P.; Vervloet, D. and Zoppi, M. (1993) Monogr. Allergy, 31, 147-170.
2. Roujeau, J. C. and Stern, R. S. (1994) N. Engl. J. Med., 331(19), 1272-1285.
3. Pichler, W. J.; Schnyder, B.; Zanni, M. P.; Hari, Y. and von Greyerz, S. (1998) Allergy, 53(3), 225-232.
4. Von Greyerz, S.; Burkhart, C. and Pichler, W. J. (1999) Int. Arch. Allergy Immunol., 119(3), 173-180.
5. Zanni, M. P.; Schnyder, B.; von Greyerz, S. and Pichler, W. J. (1998) Trends Pharmacol. Sci., 19(8), 308-310.
6. Brander, C.; Mauri-Hellweg, D.; Bettens, F.; Rolli, H.; Goldman, M. and Pichler, W. J. (1995) J. Immunol., 155(5), 2670-2678.
7. Mauri-Hellweg, D.; Bettens, F.; Mauri, D.; Brander, C.; Hunziker, T. and Pichler, W. J. (1995) J. Immunol., 155(1), 462-472.
8. Weltzien, H. U.; Moulon, C.; Martin, S.; Padovan, E.; Hartmann, U. and Kohler, J. (1996) Toxicology, 107(2), 141-151.
9. Padovan, E.; Bauer, T.; Tongio, M. M.; Kalbacher, H. and Weltzien, H. U. (1997) Eur. J. Immunol., 27(6), 1303-1307.
10. Schnyder, B.; Mauri-Hellweg, D.; Zanni, M.; Bettens, F. and Pichler, W. J. (1997) J. Clin. Invest., 100(1), 136-141.
11. Zanni, M. P.; von Greyerz, S.; Schnyder, B.; Wendland, T. and Pichler, W. J. (1998) Int. Immunol., 10(4), 507-515.
12. Zanni, M. P.; von Greyerz, S.; Schnyder, B.; Brander, K. A.; Frutig, K.; Hari, Y.; Valitutti, S. and Pichler, W. J. (1998) J. Clin. Invest., 102(8), p1591-1598.
13. Schnyder, B.; Frutig, K.; Mauri-Hellweg, D.; Limat, A.; Yawalkar, N. and Pichler, W. J. (1998) Clin. Exp. Allergy, 28(11), 1412-1417.
14. Yawalkar, N.; Hari, Y.; Frutig, K.; Egli, F.; Wendland, T.; Braathen, L. R. and Pichler, W. J. (2000) J. Invest. Dermatol., 115, 647-652.
15. Britschgi, M.; Steiner, U. C.; Schmid, S.; Depta, J. P.; Senti, G.; Bircher, A.; Burkhart, C.; Yawalkar, N. and Pichler, W. J. (2001) J. Clin. Invest., 107(11), 1433-1441.
16. De Swarte, R. D. (1993) In Allergic Diseases, (Pattersomn, R., Grammer, L. C., Greenberger, P. A. and Zeiss, C. R. Ed.), J.B. Lippincott Co., Philadelphia, pp. 395-552.
17. Marik, P. (1999) Pharmacotherapy, 19(3), 346-348.
18. Maria, V. A. and Victorino, R. M. (1997) Gut, 41, 534-540.
19. Pichler, W. J.; Schnyder, B. and Zanni, M. (1997) N. Engl. J. Med., 336(5), 377.
20. Mesec, A.; Rot, U.; Perkovic, T.; Lunder, T. and Sibanc, B. (1999) J. Neurol. Neurosurg. Psychiatry, 66(2), 249-250.
21. Lecoeur, S.; Andre, C. and Beaune, P. H. (1996) Mol. Pharmacol., 50(2), 326-333.
22. Von Boxberg, C.; Breidenbach, K.; Hohler, H. and Kobberling, J. (1998) Dtsch. Med. Wochenschr., 123(28-29), 866-870.
23. Kristofferson, A. and Nilsson, B. S. (1989) In Autoimmunity and Toxicology, (Kammüller, M. E.; Bloksma, N. and Seinen, W. Ed.), Elsevier, pp. 183-210.
24. Salama, A. and Mueller-Eckhardt, C. (1985) N. Engl. J. Med., 313(8), 469-474.
25. Landsteiner, K. and Jacoby, J. (1935) J. Exp. Med., 61, 643-656.
26. Park, B. K.; Pirmohamed, M. and Kitteringham, N. R. (1998) Chem. Res. Toxicol., 11, 969-987.
27. Griem, P.; Wulferink, M.; Sachs, B.; Gonzalez, J. B. and Gleichmann, E. (1998) Immunol. Today, 19(3), 133-141.
28. Schneider, C. H. and de Weck, A. L. (1966) Helv. Chim. Acta, 49(5), 1695-1706.
29. Padovan, E.; Mauri-Hellweg, D.; Pichler, W. J. and Weltzien, H. U. (1996) Eur. J. Immunol., 26(1), 42-48.
30. Cribb, A. E. and Spielberg, S. P. (1992) Clin. Pharmacol. Ther., 51, 522-526.
31. Burkhart, C.; von Greyerz, S.; Depta, J. P.; Naisbitt, D. J.; Britschgi, M.; Park, K. B. and Pichler, W. J. (2001) Br. J. Pharmacol., 132(3), 623-630.
32. Naisbitt, D. J.; Gordon, S. F.; Pirmohamed, M.; Burkhart, C.; Cribb, A. E.; Pichler, W. J. and Park, B. K. (2001) Br. J. Pharmacol., 133(2), 295-305.
33. Schnyder, B.; Burkhart, C.; Schnyder-Frutig, K.; von Greyerz, S.; Naisbitt, D. J.; Pirmohamed, M.; Park, B. K. and Pichler, W. J. (2000) J. Immunol., 164(12), 6647-6654.
34. Bloksma, N.; Kubicka-Muranyi, M.; Schuppe, H. C.; Gleichmann, E. and Gleichmann, H. (1995) Crit. Rev. Toxicol., 25(5), 369-396.
35. Goebel, C.; Griem, P.; Sachs, B.; Bloksma, N. and Gleichmann, E. (1996) Inflamm. Res., 45(2), 85-90.
36. Kimber, I.; Pichowski, J. S.; Basketter, D. A. and Dearman, R. J. (1999) Toxicol. Lett., 106(2-3), 237-246.
37. Ewens, S.; Wulferink, M.; Goebel, C. and Gleichmann, E. (1999) Arch. Toxicol., 73(3), 159-167.
38. Pichler, W. J. (2001) Toxicology, 158(1), 31-41.
39. Mauri-Hellweg, D.; Zanni, M.; Frei, E.; Bettens, F.; Brander, C.; Mauri, D.; Padovan, E.; Weltzien, H. U. and Pichler, W. J. (1996) J. Immunol., 157(3), 1071-1109.
40. Zanni, M. P.; Mauri-Hellweg, D.; Brander, C.; Wendland, T.; Schnyder, B.; Frei, E.; von Greyerz, S.; Bircher, A. and Pichler, W. J. (1997) J. Immunol., 158(3), 1139-1148.
41. Von Greyerz, S.; Zanni, M. P.; Frutig, K.; Schnyder, B.; Burkhart, C. and Pichler, W. J. (1999) J. Immunol., 162(1), 595-602.
42. Kohler, J.; Hartmann, U.; Grimm, R.; Pflugfelder, U. and Weltzien, H. U. (1997) J. Immunol., 158(2), 591-597.
43. Porcelli, S. A.; Morita, C. T. and Modlin, R. L. (1996) Curr. Opin. Immunol., 8(4), 510-516.
44. Grant, E. P.; Degano, M.; Rosat, J. P.; Stenger, S.; Modlin, R. L.; Wilson, I. A.; Porcelli, S. A. and Brenner, M. B. (1999) J. Exp. Med., 189(1), 195-205.
45. Roujeau, J. C.; Albengres, E. and Moritz, S. (1985) Int. Arch. Allergy Appl. Immunol., 78, 22-24.
46. Schnyder, B.; Zanni, M. P. and Pichler, W. J. (1997) Schweiz Med. Wochenschr., 127(9), 355-359.
47. Schnyder, B. and Pichler, W. J. (2000) Clin. Exp. Allergy, 30(4), 590-595.
48. Rhodes, J.; Chen, H.; Hall, S. R.; Beesley, J. E.; Jenkins, D. C.; Collins, P. and Zheng, B. (1995) Nature, 377(6544), p71-75.
49. Valitutti, S. and Lanzavecchia, A. (1997) Immunol. Today, 18, 299.
50. Achari, A.; Somers, D. O.; Champness, J. N.; Bryant, P. K.; Rosemond, J. and Stammers, D. K. (1997) Nat. Struct. Biol., 4(6), 490-497.
51. Sloan-Lancaster, J.; Evavold, B. D. and Allen, P. M. (1993) Nature, 363(6425), 156-159.
52. Kersh, G. J. and Allen, P. M. (1996) J. Exp. Med., 184(4), 1259-1268.
53. Evavold, B. D. and Allen, P. M. (1991) Science, 252(5010), 1308-1310.
54. De Magistris, M. T.; Alexander, J.; Coggeshall, M.; Altman, A.; Gaeta, F. C.; Grey, H. M. and Sette, A. (1992) Cell, 68(4), p625-634.
55. Sloan-Lancaster, J. and Allen, P. M. (1996) Annu. Rev. Immunol., 14, 1-27.
56. Park, B. K.; Coleman, J. W. and Kitteringham, N. R. (1987) Biochem. Pharmacol., 36(5), p581-590.
57. Van der Ven, A. J.; Mantel, M. A.; Vree, T. B.; Koopmans, P. P. and van der Meer, J. W. (1994) Br. J. Clin. Pharmacol., 38(2), p147-150.
58. Chen, Y. Z.; Matsushita, S. and Nishimura, Y. (1996) J. Immunol., 157(9), 3783-3790.
59. Jameson, S. C. and Bevan, M. J. (1995) Immunity, 2(1), 1-11.
60. Pichler, W. J.; Zanni, M.; von Greyerz, S.; Schnyder, B.; Mauri-Hellweg, D. and Wendland, T. (1997) Int. Arch. Allergy Immunol., 113(1-3), 177-180.
61. Choquet-Kastylevsky, G.; Intrator, L.; Chenal, C.; Bocquet, H.; Revuz, J. and Roujeau, J. C. (1998) Br. J. Dermatol., 139(6), 1026-1032.
62. Padovan, E.; von Greyerz, S.; Pichler, W. J. and Weltzien, H. U. (1999) J. Immunol., 162(2), 1171-1177.
63. Yawalkar, N.; Egli, F.; Hari, Y.; Nievergelt, H.; Braathen, L. R. and Pichler, W. J. (2000) Clin. Exp. Allergy, 30(6), 847-855.
64. Hari, Y.; Frutig-Schnyder, K.; Hurni, M.; Yawalkar, N.; Zanni, M. P.; Schnyder, B.; Kappeler, A.; Von Greyerz, S.; Braathen, L. R. and Pichler, W. J. (2001) Clin. Exp. Allergy, 31(9), 1398-1408.
65. Hertl, M. and Merk, H. F. (1995) J. Invest. Dermatol., 105(1 Suppl.), 95S-98S.
66. Beylot, C.; Bioulac, P. and Doutre, M. S. (1980) Ann. Dermatol. Venerol., 107, 37-48.
67. Roujeau, J.; Bioulac-Sage, P. and Bourseau, C. (1991) Arch. Dermatol., 127, 1333-1338.
68. Britschgi, M. and Pichler, W.J. (2002) Curr. Opin. Allergy Clin. Immunol., 2(4), 325-331.
69. Pichler, W.J. (2002) Curr. Opin. Allergy Clin. Immunol., 2(4), 301-305.
70. Burkhart, C.; Britschgi, M.; Strasser, I.; Depta, J.P.H.; von Greyerz, S.; Barnaba, V. and Pichler, W.J. (2002) Clin. Exp. Allergy, (in press).
71. Schmid, S.; Kuechler, P.C.; Britschgi, M.; Urs, C. Steiner, U.C.; Yawalkar, N.; Limat, A.; Baltensperger, K.; Braathen, L. and Pichler, W.J. (2002) Am. J. Pathol., (in press).
72. Pichler, W.J.; Yawalkar, N.; Britschgi, M.; Depta, J.; Strasser, I.; Schmid, S.; Kuechler, P. and Naisbitt, D. (2002) Am. J. Clin. Dermatol., 3(4), 229-238.